One Pass Tirofiban In Management of Ischemic Stroke Thrombectomy In China

PHASE2CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

April 6, 2021

Primary Completion Date

July 8, 2023

Study Completion Date

October 15, 2023

Conditions
Ischemic Stroke
Interventions
DRUG

Intravenous tirofiban combination therapy

Patients will enter the tirofiban treatment protocol immediately within half an hour after randomization and prior to the femoral artery puncture. Tirofiban is administered as an intravenous bolus dose of 10 μg/kg injection within 3 min and then by an intravenous infusion at a rate of 0.1 μg/(kg·min) for 24 hours.

Trial Locations (1)

200123

Gang Li, Shanghai

All Listed Sponsors
collaborator

Shanghai 6th People's Hospital

OTHER

collaborator

Ningbo No. 1 Hospital

OTHER

collaborator

Zhangzhou Municipal Hospital of Fujian Province

OTHER

collaborator

Shanghai 7th People's Hospital

OTHER

collaborator

Jinan Central Hospital

OTHER

collaborator

Xuchang Central Hospital

UNKNOWN

lead

Shanghai East Hospital

OTHER

NCT04851457 - One Pass Tirofiban In Management of Ischemic Stroke Thrombectomy In China | Biotech Hunter | Biotech Hunter